Highlight

RESEARCH 2006, September 19   Proteomics platform: The CHU strides ahead     Just like Grenoble and Toulouse, Poitiers Hospital (the CHU) is presently equipping itself with a first-class proteomics platform. Here are Jean-Louis Fauchère’s explanations. It all started two years ago. Since 2004, the CHU biology pole has been going all out to bring one of the site’s projects into being: a proteomics platform – or rather, in Jean-Louis Fauchère’s words, a “proteome-genome platform”. The pole coordinator, who is in charge of the hospital’s bacteriology ward, at first addressed an application to local administrations, the university, and his own establishment. Positive echoes were few and far between, and that is essentially why Fauchère decided to “prime the pump” by investing in equipment permitting the “rough-hewing of biomarker searchers”. “It is an apparatus that answers some needs of the medicine consisting in the systematic search of biomarkers from highly diversified human materials such as cancer cells, normal ones, sera…”, Jean-Louis Fauchère elaborates. The ultimate objective is to determine the profile of the proteins contained in these materials. Analysis of the human genome has indeed highlighted the role of proteins in the functioning and development of the human organism. This work could take place at Poitiers Hospital on account of “the large number of materials available, both pathogenic and healthy”. A large-scale construction site Elaboration of the proteins’ profiles consequently constitutes the platform’s initial stage. “After that, it shall be necessary to determine which proteins are the most interesting for a diagnosis, prognosis or therapeutic follow-up test. These tests enable us to say, in accordance with the biomarkers, whether the evolution is favorable or unfavorable”, Professor Fauchère goes on to indicate. It stands to reason that it will take a great deal of work to establish the correlation between observed clinical signs and the biological profiles observed thanks to proteomics techniques. “Were we to get that far, we would be quite pleased…”, acknowledges the coordinator of the CHU biology pole. This is due to the fact that the next stage of the process (how does a normal cell come to be pathogenic?) necessitates “the labor of basic research”, which the hospital center lacks the wherewithal to underwrite. “We may dispose of data banks, notably via the Internet. What stops us is that we don’t quite know how to use them, and that the right apparatuses are lacking.” The Biopole en masse at Eurobio 2008 Read ...   Water information days (September 23 – September 25) Read ...   The rose and its genetic transformation Read ...   Christian Huyghe aims for “excellence” read...   Creating “medical branches” read...   A neuro-cardio-vascular pole is taking root read...   Valagro on the horticulture market read...   ERM, the winning spin-off read...   GMOs under debate in Poitiers read...   Isabelle Cameleyre, new representative read...   Cystic fibrosis: The molecule of hope read...   Irfaq, a manufacturer of innovations read...   CHU: State-of-the-art quality read...   Soil organic matter under examination read...   Parexel: The Cap provides its support read...   Philippe Michonneau: “The Biopole, fertile soil” read...   Painless monitoring of hepatitis read...   The Biopole structured as an association read...   Futuramat steps up the pace read...   Technova, or life in 3D read...   B Braun burnishes its image read...   Proteomics platform: The CHU strides ahead read...   The three missions of the University Botanical Garden read...   Clinsight in the big leagues read...   Natural energies for an autonomous building read...   Aster-Cephac turns into SGS Cephac read...   The previously unseen heart read...   BIOalternatives diversifies its markets read...   Two Poitiers-based projects awarded read...   IUT pores over biofuels read...   Poitiers, the biotechnology capital read...   PAREXEL wagers on the human factor read...   Saunier and associates wish to diversify read...   Biocydex and BioXtract move forward hand in hand read...   The grass of champions read...   Ianesco steadfastly believes in its future read...   A tumorotheque, what is the purpose it serves? read...   TechnAvOx has turned the corner read...   Larime is aiming for 40 beds in Poitiers read...   Poitiers is out to promote its research read...   A true Biopole milestone read...   A regional cancerology pole in the pipeline for 2007 read...   Nobel prize winners in Poitiers read...   A platform offering numerous advantages read...   @rtMolecule fashions in its own way read...   It’s plastic, it’s fantastic read...   The Poitiers hospital (CHU) stakes its claim read...   BIOalternatives exports its know-how read...   The physiological and computer science engineering program turns 30 read...   The Biopole takes center stage at Investiga read...           Legal mentions